Zymor-AP Tablet is a combination analgesic and anti-inflammatory medication containing Aceclofenac 100mg, Paracetamol 325mg, and Trypsin Chymotrypsin 150,000 AU. Aceclofenac, a non-steroidal anti-inflammatory drug (NSAID), exerts potent anti-inflammatory, analgesic, and antipyretic effects by inhibiting cyclooxygenase enzymes, thereby reducing prostaglandin synthesis. Paracetamol provides additional analgesic and antipyretic benefits through central inhibition of prostaglandin synthesis, complementing the action of Aceclofenac. Trypsin Chymotrypsin, a proteolytic enzyme complex, aids in reducing inflammation and edema by promoting the breakdown of proteinaceous exudates and facilitating tissue repair. This combination is indicated for the management of acute and chronic musculoskeletal conditions such as osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and postoperative pain and inflammation. Zymor-AP Tablet offers effective relief from pain, swelling, and inflammation, improving patient mobility and quality of life. It should be used under medical supervision, with caution in patients with a history of gastrointestinal ulcers, hepatic or renal impairment, and hypersensitivity to NSAIDs or any component of the formulation. Common adverse effects may include gastrointestinal discomfort, nausea, and hypersensitivity reactions. The dosage and duration of therapy should be tailored according to clinical response and patient tolerance.